| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |